Control group | Intervention group | |||
---|---|---|---|---|
Men mean (CI) | Women mean (CI) | Men mean (CI) | Women mean (CI) | |
Weight (Kg) | 1.95(0.47-3.44)** | −0.63(−2.19-0.92) | −0.05 (−3.13-3.02) | −0.50(−1.82-0.82) |
SPB (mm Hg) | 13.08(0.53-25.63)* | −3.13(−8.73-2.46) | −4.33(−20-11.44) | −4.65(−10.27-1.41) |
DPB (mm Hg) | 0.83(−4.83-6.49) | −0.04(2.40-2.31) | −4.50(−16-7.08) | 1.43(−2.93-5.80) |
HRr (B/min) | −3.75(−9.86-2.36) | −4.5(−8.45-(−0.54)* | −2.16(−5.80-1.47) | 1.04(−2.64-4.72) |
HRmax (B/min) | −0.58(−1.86-0.70) | −0.09(−0.32-0.142) | −0.42(−1.23-0.40) | −1.78(−4.62-1.05) |
HRfinal (B/min) | 4(−1.92-9.92) | 1.72(−4.75-8.21) | 1(−6.01-8.01) | 3.82(−4.09-11.74) |
RPE | 0.83(−0.13-1.80) | 0.91(0.22-1.59)** | 0.22(−0.60-1.05) | 0.39(−0.29-1.07) |
FVC (L) | 0.82(0.33-1.31) | 0.38(−0.09-0.85) | 0.73(0.18-1.27)** | 0.10(−0.06-0.27) |
FEV1 (L) | 0.06(−0.38-0.51) | −0.02(−0.24-0.19) | 0.11(−0.03-0.26) | −0.07(−0.23-0.08) |
FEV1/FVC (%) | 17.47(−28.01-(−6.95) | −1.22(−11.30-8.85) | −10.45(−18.6-(−2.23)** | 5.17(−11.45-1.11) |
EQ-5D (0–1) | −0.24(−0.43-0.043)* | 0.065(−0.166-0.03) | 0.02(−0.18-0.23) | 0.14(−0.30-0.01) |
Physical role (0–100) | 0(−7.27-7.27) | 3.43(−1.14-8.01) | 1.16(−5.12-8.34) | 4.29(−0.619-9.21) |
Social (0–100) | 10.09(−8.45-28.65) | 1.12(−12.58-14.81) | 10.09(−8.45-28.65) | 8.07(−21.81-5.65) |
Body Pain (0–100) | 7.64(−0.46-15.75)* | 8.33(0.95-15.72)* | 5.09(−4.26-14.45) | 5.09(−4.26-14.45) |
General Health (0–100) | 1.23(−2.69-5.16) | 0.43(−3.18-2.32) | 3.50(−7.58-0.58) | 0.95(−3.29-1.37) |
Vitality(0–100) | 8.51(−1.67-18.70) | 0(−5.11-5.11) | 2.87(−5.15-10.90) | 2.68(−5.32-10.69) |
Mental(0–100) | 2.03(−9.17-13.23) | 3.04(−15.42-9.32) | 1.74(−10.31-13.79) | 6.70(−3.03-16.44) |